{"id":"https://openalex.org/W1978253274","doi":"https://doi.org/10.1021/jm0303195","title":"Classification of Kinase Inhibitors Using a Bayesian Model","display_name":"Classification of Kinase Inhibitors Using a Bayesian Model","publication_year":2004,"publication_date":"2004-08-01","ids":{"openalex":"https://openalex.org/W1978253274","doi":"https://doi.org/10.1021/jm0303195","mag":"1978253274","pmid":"https://pubmed.ncbi.nlm.nih.gov/15317458"},"language":"en","primary_location":{"id":"doi:10.1021/jm0303195","doi":"https://doi.org/10.1021/jm0303195","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm0303195","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1978253274"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090524391","display_name":"Xiaoyang Xia","orcid":"https://orcid.org/0000-0001-9637-6106","observed_orcids":["https://orcid.org/0000-0001-9637-6106"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Xiaoyang Xia","raw_affiliation_strings":["Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and SciTegic, 9665 Chesapeake Drive, Suite 401, San Diego, California 92123"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and SciTegic, 9665 Chesapeake Drive, Suite 401, San Diego, California 92123","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057216137","display_name":"Edward G. Maliski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward G. Maliski","raw_affiliation_strings":["Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and SciTegic, 9665 Chesapeake Drive, Suite 401, San Diego, California 92123"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and SciTegic, 9665 Chesapeake Drive, Suite 401, San Diego, California 92123","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024440471","display_name":"Paul Gallant","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Gallant","raw_affiliation_strings":["Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and SciTegic, 9665 Chesapeake Drive, Suite 401, San Diego, California 92123"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and SciTegic, 9665 Chesapeake Drive, Suite 401, San Diego, California 92123","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012560979","display_name":"David O. Williams Rogers","orcid":"https://orcid.org/0000-0002-5187-1768","observed_orcids":["https://orcid.org/0000-0002-5187-1768","https://orcid.org/0000-0001-8196-4503"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Rogers","raw_affiliation_strings":["Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and SciTegic, 9665 Chesapeake Drive, Suite 401, San Diego, California 92123"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and SciTegic, 9665 Chesapeake Drive, Suite 401, San Diego, California 92123","institution_ids":["https://openalex.org/I1320553840"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5090524391"],"corresponding_institution_ids":["https://openalex.org/I1320553840"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":2.9705,"has_fulltext":false,"cited_by_count":352,"citation_normalized_percentile":{"value":0.91401772,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"47","issue":"18","first_page":"4463","last_page":"4470"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11948","display_name":"Machine Learning in Materials Science","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kinase-inhibitors","display_name":"kinase inhibitors","score":0.9919999837875366},{"id":"https://openalex.org/keywords/bayesian-model","display_name":"Bayesian model","score":0.6539999842643738},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.8349999785423279},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9160000085830688},{"id":"https://openalex.org/keywords/serine-threonine-kinase-inhibitors","display_name":"serine/threonine kinase inhibitors","score":0.9660000205039978},{"id":"https://openalex.org/keywords/compound-prioritization","display_name":"compound prioritization","score":0.6690000295639038},{"id":"https://openalex.org/keywords/compound-screening","display_name":"compound screening","score":0.5230000019073486}],"concepts":[{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.6004727482795715},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.5446306467056274},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5096075534820557},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.47983548045158386},{"id":"https://openalex.org/C107673813","wikidata":"https://www.wikidata.org/wiki/Q812534","display_name":"Bayesian probability","level":2,"score":0.4706006944179535},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.39394593238830566},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.34422725439071655},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.2555153965950012},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.19738435745239258},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.16794541478157043}],"mesh":[{"descriptor_ui":"D001185","descriptor_name":"Artificial Intelligence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001499","descriptor_name":"Bayes Theorem","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010770","descriptor_name":"Phosphotransferases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1021/jm0303195","doi":"https://doi.org/10.1021/jm0303195","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm0303195","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:15317458","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15317458","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.136.2575","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.136.2575","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.ics.uci.edu/~welling/teaching/ICS274Bspring06/Amgen-Bayesian.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W1517570969","https://openalex.org/W1518917862","https://openalex.org/W1597224949","https://openalex.org/W1972333505","https://openalex.org/W1989141250","https://openalex.org/W1994126845","https://openalex.org/W2001633251","https://openalex.org/W2002925793","https://openalex.org/W2005685204","https://openalex.org/W2019980219","https://openalex.org/W2022116853","https://openalex.org/W2030924205","https://openalex.org/W2032726880","https://openalex.org/W2055415068","https://openalex.org/W2057213963","https://openalex.org/W2059280933","https://openalex.org/W2061959536","https://openalex.org/W2063060349","https://openalex.org/W2081050523","https://openalex.org/W2127644822","https://openalex.org/W2140151458","https://openalex.org/W2155591132","https://openalex.org/W2164165673","https://openalex.org/W2164640330","https://openalex.org/W2473312901","https://openalex.org/W2796557543","https://openalex.org/W2951803487","https://openalex.org/W4206507674","https://openalex.org/W4231458444"],"related_works":["https://openalex.org/W4385971578","https://openalex.org/W2995767772","https://openalex.org/W7112797802","https://openalex.org/W2494869284","https://openalex.org/W2802536107","https://openalex.org/W3107564280","https://openalex.org/W1983782238","https://openalex.org/W2998862306","https://openalex.org/W3164680581","https://openalex.org/W2171833157"],"abstract_inverted_index":{"The":[0,17,81,114],"use":[1],"of":[2,84,124,149],"Bayesian":[3],"statistics":[4],"to":[5,22,27,67,73,95,108,152],"model":[6,44,117],"both":[7],"general":[8,115],"(multifamily)":[9],"and":[10,36],"specific":[11,58,111],"(single-target)":[12],"kinase":[13,51,59,112,116,127,144,154],"inhibitors":[14],"is":[15,37,87,104],"investigated.":[16],"approach":[18,33,63,86],"demonstrates":[19],"an":[20,62],"alternative":[21],"current":[23],"computational":[24],"methods":[25],"applied":[26],"heterogeneous":[28],"structure/activity":[29],"data":[30,48,79],"sets.":[31],"This":[32],"operates":[34],"rapidly":[35],"readily":[38],"modifiable":[39],"as":[40],"required.":[41],"A":[42],"generalized":[43],"generated":[45],"using":[46],"inhibitor":[47],"from":[49,77,121],"multiple":[50],"classes":[52],"shows":[53],"meaningful":[54],"enrichment":[55],"for":[56,70,101],"several":[57],"targets.":[60,145],"Such":[61],"can":[64],"be":[65,157],"used":[66,137],"prioritize":[68],"compounds":[69,76,89],"screening":[71],"or":[72,98],"optimally":[74],"select":[75],"third-party":[78],"collections.":[80],"observed":[82],"benefit":[83],"the":[85,134,147],"finding":[88],"that":[90],"are":[91],"not":[92,105],"structurally":[93],"related":[94],"known":[96],"actives,":[97],"novel":[99],"targets":[100],"which":[102],"there":[103],"enough":[106],"information":[107],"build":[109],"a":[110,122],"model.":[113],"described":[118],"was":[119],"built":[120],"basis":[123],"mostly":[125],"tyrosine":[126,143],"inhibitors,":[128],"with":[129],"some":[130],"serine/threonine":[131],"inhibitors;":[132],"all":[133],"test":[135],"cases":[136],"in":[138],"prediction":[139],"were":[140],"also":[141],"on":[142],"Confirming":[146],"applicability":[148],"this":[150],"technique":[151],"other":[153],"families":[155],"will":[156],"determined":[158],"once":[159],"those":[160],"biological":[161],"assays":[162],"become":[163],"available.":[164]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":20},{"year":2023,"cited_by_count":15},{"year":2022,"cited_by_count":32},{"year":2021,"cited_by_count":34},{"year":2020,"cited_by_count":15},{"year":2019,"cited_by_count":26},{"year":2018,"cited_by_count":19},{"year":2017,"cited_by_count":15},{"year":2016,"cited_by_count":17},{"year":2015,"cited_by_count":16},{"year":2014,"cited_by_count":17},{"year":2013,"cited_by_count":13},{"year":2012,"cited_by_count":14}],"updated_date":"2026-11-13T13:42:25.865203","created_date":"2016-06-24T00:00:00"}